Proposed
Bill · 119th Congress · HR 6321
Lung Cancer Medicare Access to Precise Testing Act
Refreshed 3 h ago
Introduced 2025-11-28Topic: health careSummary
AI-generated summary, report an errorThis bill would add lung cancer biomarker testing to the services covered under Medicare. The testing covered is a test given on or after January 1, 2027, to a person diagnosed with lung cancer to identify one or more biomarkers, such as genes or proteins, using the person's tissue, blood, or bodily fluids. Medicare would pay 100 percent of the reasonable charges for this testing.
Sponsors
- Josh Gottheimer Democrat sponsor
- 2 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2025-11-28 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2025-11-28 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2025-11-28 | Introduced in House | introduce | |
| 2025-11-28 | Introduced in House | introduce |